- Scrip Originals
- Featured Topics
Brought to you by
Eisai, Broad Institute seek to develop malaria therapies
05 Jun 2017
Eisai Inc. and the Broad Institute are building on an existing partnership to develop antimalarials.
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com